ArticlePloS one2025
Assessing changes in ultraviolet radiation-exposed mouse skin using optical coherence tomography.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Characterising the urinary excretion of thymidine dimer photolesions in mice.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Skin cancer is one of the most common types of cancer, frequently resulting from excessive exposure to ultraviolet radiation (UVR). Early detection and effective prevention of photodamage are important to mitigate the long-term risks of skin cancer. In this study, we investigate the use of optical coherence tomography (OCT) for assessing photodamage over time and the efficacy of photodamage prevention treatments non-invasively. Of the n = 81 hairless mice, 75 of them were exposed to ultraviolet radiation (UVR) three times per week to induce photodamage. Two different systemic photodamage prevention treatments were tested: nicotinamide mononucleotide (NMN) and polypodium leucotomos (PL). OCT images were acquired monthly on the back, side, and stomach of the mice over 7 months. Two OCT-derived metrics, skin thickness and the attenuation coefficient, [Formula: see text], were quantified using a custom-developed algorithm to evaluate photodamage. Significant differences in skin thickness (p = 0.038) and attenuation coefficient (p<0.001) were observed between the UVR control group and the non-irradiated control group after 7 months at the back. At month 7, no significant difference was observed in the attenuation coefficient between the UVR control group and the UVR + PL group, however, a significant difference was observed between the UVR control group and the UVR + NMN group. Additionally, our OCT-derived skin thickness was well correlated with the skin thickness measured from histology, demonstrating a strong alignment with these invasive ground truth findings. Altogether, our results indicate that OCT could be a useful tool for non-invasive monitoring of photodamage in skin and for monitoring the efficacy of photodamage prevention treatments.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.